本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Tarsus Pharmaceuticals, Inc.

72.81
+0.11000.15%
成交量:41.41萬
成交額:3,011.61萬
市值:31.95億
市盈率:-67.27
高:73.08
開:72.88
低:71.77
收:72.70
52周最高:85.25
52周最低:48.20
股本:4,388.30萬
流通股本:3,267.99萬
量比:0.67
換手率:1.27%
股息:- -
股息率:- -
每股收益(TTM):-1.0824
每股收益(LYR):-1.5900
淨資產收益率:-13.68%
總資產收益率:-5.48%
市淨率:9.21
市盈率(LYR):-45.79

資料載入中...

2026/08/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/08/06

重要事件披露

Form 8-K - Current report
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/13

重要事件披露

Form 8-K - Current report
2026/07/08

重要事件披露

Form 8-K - Current report
2026/06/29

重要事件披露

Form 8-K - Current report
2026/06/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/08

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

重要事件披露

Form 8-K - Current report
2026/03/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities